September 23, 2014 3:39 AM ET

Pharmaceuticals

Company Overview of Proteostasis Therapeutics, Inc.

Company Overview

Proteostasis Therapeutics, Inc. engages in discovering and developing small molecule drugs that restore protein function to treat neurodegenerative, metabolic, genetic, and inflammatory disorders. Its products include therapies or Proteostasis regulators to treat various genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as Alzheimer's disease, emphysema, Huntington's disease, and type II diabetes. The company develops its small molecule therapeutics to control the body's protein homeostasis or Proteostasis Network, which is cellular machinery for protein folding, trafficking, and clearance to maintain the body's balance of proteins. Proteostasi...

200 Technology Square

Suite 402

Cambridge, MA 02139

United States

Founded in 2007

Phone:

617-225-0096

Fax:

617-632-5739

Key Executives for Proteostasis Therapeutics, Inc.

Chief Executive Officer
Age: 40
Head of External Innovation
Head of Chemistry
Head of Systems Biology
Head of Translational Biology
Compensation as of Fiscal Year 2014.

Proteostasis Therapeutics, Inc. Key Developments

Proteostasis Therapeutics, Inc. Appoints Meenu Chhabra as President and Chief Executive Officer

Proteostasis Therapeutics, Inc. announced the appointment of Meenu Chhabra as President and Chief Executive Officer. Ms. Chhabra, who will also serve on the Company's Board of Directors, has extensive managerial experience in the biopharmaceutical industry with a strong track record of corporate execution. Her initial focus will be driving the development of the Company's cystic fibrosis franchise while leveraging its proteostasis platform to identify pipeline appropriate assets addressing orphan and neurodegenerative disease indications. Prior to joining Proteostasis, Ms. Chhabra served as the President and Chief Executive Officer since August 2007 at Allozyne, Inc.

Proteostasis Therapeutics, Inc. Presents at 2014 Wells Fargo Healthcare Conference, Jun-17-2014 through Jun-18-2014

Proteostasis Therapeutics, Inc. Presents at 2014 Wells Fargo Healthcare Conference, Jun-17-2014 through Jun-18-2014. Venue: InterContinental Hotel Boston, 510 Atlantic Avenu, Boston, MA 02210, United States. Presentation Date(s): Jun-18-2014.

Proteostasis Therapeutics, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 10:20 AM

Proteostasis Therapeutics, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 10:20 AM. Venue: The Westin Grand Central Hotel, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Dartmouth-Hitchcock Clinic United States
Biosyntrx, Inc. United States
Hoffmann-La Roche Inc. United States
Neurorecovery, Inc. United States
Device Partners International, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 31, 2014
--
Private Placement
December 9, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Proteostasis Therapeutics, Inc., please visit www.proteostasis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.